ARTICLE | Company News
Genzyme, Novel Diagnostics ASA deal
June 20, 2005 7:00 AM UTC
Novel Diagnostics' NorDiag AS unit licensed European rights to GENZ's p53 and APC genes. NorDiag plans to use the markers in its Genefec assay for the early detection of colorectal cancer. ...